Vaccines

Pfizer Announces Launch of Bivalent RSV Vaccine in Hong Kong and Macau

Pfizer Inc. has announced the availability of its bivalent RSV prefusion F (RSVpreF) vaccine in Hong Kong this month. Approved by health authorities in Hon...

 July 19, 2024 | News

Indian Immunologicals Donates 10,000 Doses of Anti-Rabies Vaccine to Vulnerable Communities in Vietnam

Indian Immunologicals Ltd (IIL), led by its Chairman Dr. Meenesh Shah and Managing Director Dr. K. Anand Kumar, has generously donated 10,000 doses of its ...

 July 17, 2024 | News

Sabin Vaccine Institute Launches Phase 2 Trial for Sudan Ebolavirus Vaccine in Uganda

Sabin Vaccine Institute launched a Phase 2 clinical trial for its vaccine against Sudan ebolavirus, with healthy volunteers receiving the single-...

 July 16, 2024 | News

Merck and Afrigen Partner in South Africa to Develop mRNA Platform Technology, Boosting Global Vaccine Access

Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization Contributes to expand...

 July 05, 2024 | News

PharmaJet’s Needle-Free Tropis® System to Drive House-to-House Polio Immunization Campaign in Somalia

PharmaJet®, a company dedicated to enhancing the performance and outcomes of injectables through innovative delivery systems, today announced that thei...

 June 28, 2024 | News

Pfizer and BioNTech's Omicron JN.1 COVID-19 Vaccine Receives CHMP Recommendation

The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older Re...

 June 28, 2024 | News

ILiAD Biotechnologies Selects Emmes Group for Global Phase III Trials of BPZE1 Pertussis Vaccine

Multiple Phase III studies are expected to be conducted across North America, Central and South America, UK and other global clinical sites VaxTrials, p...

 June 25, 2024 | News

FDA Approves GSK's AREXVY Vaccine for High-Risk Adults Aged 50-59

Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes1 Clinical development program conti...

 June 10, 2024 | News

Thermo Fisher Scientific Opens Cutting-Edge Ultra-Cold Facility in EU to Boost Advanced Therapy Development

Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its c...

 June 03, 2024 | News

Serum Institute of India Acquires 20% Stake in IntegriMedical to Accelerate Development of Needle-Free Injection Technology

-       With this investment, SII will acquire 20% stake in IntegriMedical   -      ...

 May 20, 2024 | News

Overcoming Vaccine Access Challenges in Asia Pacific: Perspectives from DKSH's Reuben Ong

  Timely access to vaccines is crucial for public health, especially in regions with diverse regulatory landscapes like the Asia Pacific. Bio...

 May 17, 2024 | Interview

HSA Approves Arexvy, World's First RSV Vaccine, for Older Adults in Singapore

The Health Sciences Authority (HSA) of Singapore has approved Arexvy (recombinant, AS01E adjuvanted) for active immunisation to prevent lower respiratory t...

 May 16, 2024 | News

WestGene Achieves FDA Approval for World's First EB Virus-Related mRNA Cancer Vaccine, WGc-043

WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, ...

 May 13, 2024 | News

Pfizer's Innovative Single-Dose Bivalent RSV Vaccine Approved in Hong Kong and Macau

  The first and only bivalent, single-dose vaccine that fights against both RSV A and RSV B disease through two seasons has been approved by Hong K...

 May 09, 2024 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close